Iceutica Operations patents expiration
1. Vivlodex patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9526734 | ICEUTICA OPERATIONS | Formulation of meloxicam |
Mar, 2033
(8 years from now) | |
| US9808468 | ICEUTICA OPERATIONS | Formulation of meloxicam |
Mar, 2035
(10 years from now) | |
| US9649318 | ICEUTICA OPERATIONS | Formulation of meloxicam |
Mar, 2035
(10 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Oct 22, 2018 |
Drugs and Companies using MELOXICAM ingredient
Market Authorisation Date: 22 October, 2015
Treatment: Management of osteoarthritis pain by administering 10 mg of meloxicam
Dosage: CAPSULE;ORAL
How can I launch a generic of VIVLODEX before it's drug patent expiration?
More Information on Dosage
VIVLODEX family patents
